Development and Current Role of Sodium Glucose Cotransporter Inhibition in Cardiorenal Metabolic Syndrome. Clements JN. J Cardiovasc Pharmacol 2022;79:593-604.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Clements JN. Development and Current Role of Sodium Glucose Cotransporter Inhibition in Cardiorenal Metabolic Syndrome. J Cardiovasc Pharmacol 2022;79:593-604.
PMID: 35522700